Last updated 2026-08-28
- Raised $789M Public Offering, Feb 2026
- Raised $500M convertible note led by Lehman Brothers Inc., Jan 2006
- Raised $22.8M Public Offering, Feb 2026
Total raised
$1.3B
Stage
Mature
Founded
—
Headcount
—
HQ
North Wales, United States
Sector
Health Tech & Life Sciences
About
Teva Pharmaceutical Finance Co, LLC is a Delaware-organized limited liability company and an indirect wholly-owned subsidiary of Teva Pharmaceutical Industries Limited, an Israeli multinational pharmaceutical company. It primarily serves as a financing vehicle for its parent company, issuing debt securities to support Teva Pharmaceutical Industries' global operations and strategic initiatives.
Funding history · 3 rounds · $1.3B total
2026-02
Public Offering
$22.8M
2026-02
Public Offering
$789.0M
2006-01
Convertible Debt
$500.0M
★ Lehman Brothers Inc.★ Citigroup Global Markets Inc.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Target customers
Business model
b2b
Tags
pharmaceuticalsfinancedebt-issuance
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Teva Pharmaceutical Finance Co, LLC |
|---|